An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers
1990

Cellular Proliferation Markers in Head and Neck Cancers

Sample size: 42 publication Evidence: moderate

Author Information

Author(s): J.H. Kearsley, K.L. Furlong, R.A. Cooke, M.J. Waters

Primary Institution: Queensland Institute of Medical Research

Hypothesis

The study investigates the significance of cellular expression of proliferation markers in head and neck squamous cell cancers.

Conclusion

The study suggests that intense expression of EGFR and TFR, along with high Ki-67 reactivity and DNA aneuploidy, may indicate a subset of head and neck cancer patients with poor clinical outcomes.

Supporting Evidence

  • All 42 fresh tumor samples expressed both EGFR and TFR.
  • 73% of samples with low Ki-67 reactivity were DNA diploid.
  • 87.5% of samples with high Ki-67 reactivity were DNA aneuploid.
  • Poorly differentiated SCCs were significantly more often aneuploid than well or moderately differentiated tumors.

Takeaway

This study looked at how certain markers in cancer cells can help doctors understand how aggressive the cancer is and how it might behave.

Methodology

The study used immunohistochemical and flow cytometric techniques to analyze tumor samples from patients with head and neck squamous cell cancers.

Limitations

The study faced challenges in accurately assessing S-phase fractions due to the high incidence of aneuploidy and small sample sizes.

Participant Demographics

The study included 42 newly diagnosed patients (30 male, 12 female) with a mean age of 66.8 years.

Statistical Information

P-Value

p=0.008 for the correlation between high tumor proliferation rate and poorer survival.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication